News

Foamix news releases

Stay up-to-date on the latest news and innovation from Foamix

 

January 17, 2020
Foamix Announces OrbiMed’s Support of Merger with Menlo Therapeutics
REHOVOT, Israel , and BRIDGEWATER, N.J. , Jan. 17, 2020 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd.  (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, announced today that OrbiMed Advisors LLC (“OrbiMed”), a significant shareholder of the Company, intends to vote
November 11, 2019
Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Conference Call and Webcast Scheduled for Monday, November 11th at 8:30am Eastern Time REHOVOT, Israel , and BRIDGEWATER, N.J. , Nov. 11, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and